<p>随着全球市场应对经济变化的复杂性，亚洲股市为价值投资者提供了引人注目的机会。在波动的指数和不断变化的经济环境中，识别被低估的股票可能是利用潜在市场低效的关键。</p>
<h3>基于现金流的亚洲十大被低估股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估算）</strong></td>
<td><strong>折扣（估算）</strong></td>
</tr>
<tr>
<td>厦门特宝生物（SHSE:688278）</td>
<td>CN¥82.99</td>
<td>CN¥165.09</td>
<td>49.7%</td>
</tr>
<tr>
<td>宝丽生物（TSE:4974）</td>
<td>¥919.00</td>
<td>¥1829.46</td>
<td>49.8%</td>
</tr>
<tr>
<td>苏州泽尔根生物制药（SHSE:688266）</td>
<td>CN¥113.00</td>
<td>CN¥223.99</td>
<td>49.6%</td>
</tr>
<tr>
<td>苏州阿尔顿电气与机械工业（SZSE:301187）</td>
<td>CN¥29.42</td>
<td>CN¥58.27</td>
<td>49.5%</td>
</tr>
<tr>
<td>南京宇宙化工（SZSE:300856）</td>
<td>CN¥14.28</td>
<td>CN¥28.44</td>
<td>49.8%</td>
</tr>
<tr>
<td>美图（SEHK:1357）</td>
<td>HK$9.21</td>
<td>HK$18.02</td>
<td>48.9%</td>
</tr>
<tr>
<td>松屋 R&amp;D（TSE:7317）</td>
<td>¥731.00</td>
<td>¥1430.21</td>
<td>48.9%</td>
</tr>
<tr>
<td>Kolmar Korea（KOSE:A161890）</td>
<td>₩79000.00</td>
<td>₩155852.26</td>
<td>49.3%</td>
</tr>
<tr>
<td>HL Holdings（KOSE:A060980）</td>
<td>₩42150.00</td>
<td>₩83199.11</td>
<td>49.3%</td>
</tr>
<tr>
<td>安徽荣德科技（SHSE:688768）</td>
<td>CN¥49.18</td>
<td>CN¥97.08</td>
<td>49.3%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们基于现金流的 280 只被低估亚洲股票的完整列表。</p>
<p>让我们更仔细地看看我们筛选出的几只股票。</p>
<h2>ASMPT（SEHK:522）</h2>
<p><strong>概述：</strong> ASMPT 有限公司是一家投资控股公司，涉及全球半导体和电子组装行业的机器、工具和材料的设计、制造和营销，市值约为 HK$295.7 亿。</p>
<p><strong>运营：</strong> 公司的收入来自半导体解决方案，贡献 HK$77.7 亿，以及表面贴装技术（SMT）解决方案，贡献 HK$55.1 亿。</p>
<p><strong>公允价值折扣估算：</strong> 44.3%</p>
<p>根据现金流，ASMPT 似乎被低估，当前交易价格为 HK$71，远低于其估算的公允价值 HK$127.41。尽管最近在深圳进行了裁员以优化运营，但公司仍保持强劲的增长前景，预计年收益增长为 40.6%，超过香港市场的 12.2%。尽管利润率从去年的 3% 降至 1.8%，ASMPT 的战略调整旨在增强成本竞争力和运营韧性。</p>
<ul>
<li>我们的 ASMPT 增长报告中的分析暗示未来财务表现强劲。</li>
<li>点击探索我们在 ASMPT 资产负债表健康报告中的详细发现。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d93ad6f1-2b1b-4cae-b992-0cc4eb72e03d/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d93ad6f1-2b1b-4cae-b992-0cc4eb72e03d/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>截至 2025 年 9 月的 SEHK:522 折现现金流</p>
<h2>新生镇（SEHK:9911）</h2>
<p><strong>概述：</strong> 新生镇有限公司是一家投资控股公司，全球运营社交网络业务，市值为 HK$171.3 亿。</p>
<p><strong>运营：</strong> 公司的收入来自两个主要部门：创新业务，贡献 CN¥6.031 亿，以及社交网络业务，贡献 CN¥54 亿。</p>
<p><strong>公允价值折扣估算：</strong> 29.5%</p>
<p>新生镇的交易价格为 HK$12.76，低于其估算的公允价值 HK$18.09，突显其基于现金流的低估。最近的收益显示出强劲的表现，2025 年上半年净收入达到 CNY 4.8928 亿，较去年 CNY 2.2468 亿有所增长。尽管最近董事会的变动可能影响战略方向，但公司的年收益增长预期为 26.5%，超过香港市场的平均水平。</p>
<ul>
<li>根据我们的收益增长报告，有迹象表明新生镇可能准备扩张。</li>
<li>点击这里访问我们的完整资产负债表健康报告，以了解新生镇的动态。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fcd5c300-fa92-45a8-85b8-008e7212a467/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fcd5c300-fa92-45a8-85b8-008e7212a467/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>截至 2025 年 9 月的 SEHK:9911 折现现金流</p>
<h2>Rorze（TSE:6323）</h2>
<p><strong>概述：</strong> Rorze 公司设计、开发、制造和销售全球半导体和液晶显示器生产的自动化系统，市值为¥3128.7 亿。</p>
<p><strong>运营：</strong> 公司的收入来自全球半导体和液晶显示器生产的自动化系统的设计、开发、制造和销售。</p>
<p><strong>公允价值折扣估算：</strong> 34.2%</p>
<p>Rorze 的交易价格为¥1804，显著低于其估算的公允价值¥2740.71。尽管利润率从 23.4% 降至 15.7%，但公司仍然具有良好的价值，交易价格比公允价值估算低 34.2%。预计年收益将增长 15.81%，超过日本市场的平均水平 8.3%。最近完成的价值¥49.9994 亿的股票回购计划可能在高股价波动中提升股东价值。</p>
<ul>
<li>我们的综合增长报告提出 Rorze 可能面临显著的财务增长机会。</li>
<li>点击这里阅读我们的健康报告，深入了解 Rorze 的资产负债表。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4d659f8c-73ac-4638-abf7-18dec4e4fb14/chart/dcf/query-dGhlbWU9bGlnaHQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4d659f8c-73ac-4638-abf7-18dec4e4fb14/chart/dcf/query-dGhlbWU9bGlnaHQ"/></p>
<p>截至 2025 年 9 月的 TSE:6323 折现现金流</p>
<h2>让它发生</h2>
<ul>
<li>点击这里访问我们完整的 280 只基于现金流的被低估亚洲股票索引。</li>
<li>已经拥有这些公司？通过将您的投资组合与 Simply Wall St 连接，清晰化您的投资决策，您可以轻松监控所有股票的关键指标。</li>
<li>使用 Simply Wall St 应用程序提升您的投资能力，享受免费访问涵盖每个大洲的市场情报。</li>
</ul>
<h2>准备探索其他投资风格吗？</h2>
<ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过稳健的分红支付者来多样化您的投资组合，以提供可靠的收入来源，以应对潜在的市场动荡。</li>
<li>充实您的投资组合，选择那些显示出强劲增长潜力的公司，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
<p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章并不构成财务建议。它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>

特宝生物

00522

<p>亚洲股市为价值投资者提供了显著的机会，因为他们正在应对经济变化。根据现金流评估的前 10 只被低估股票名单中，包括厦门特宝生物和高桥生物，公允价值的折扣范围在 48.9% 到 49.8% 之间。值得注意的还有 ASMPT 和 Newborn Town，这两家公司均低于其估计的公允价值，显示出增长潜力。分析师建议，这些股票可能会利用市场低效，使其成为投资的吸引选择</p>

<p>As global markets navigate the complexities of economic shifts, Asian stock markets present intriguing opportunities for value investors. Amidst fluctuating indices and evolving economic landscapes, identifying stocks that are undervalued can be key to capitalizing on potential market inefficiencies.</p>
<div class="lb-trans"><p>随着全球市场应对经济变化的复杂性，亚洲股市为价值投资者提供了引人注目的机会。在波动的指数和不断变化的经济环境中，识别被低估的股票可能是利用潜在市场低效的关键。</p>
</div><h3>Top 10 Undervalued Stocks Based On Cash Flows In Asia</h3>
<div class="lb-trans"><h3>基于现金流的亚洲十大被低估股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Current Price</strong></td>
<td><strong>Fair Value (Est)</strong></td>
<td><strong>Discount (Est)</strong></td>
</tr>
<tr>
<td>Xiamen Amoytop Biotech (SHSE:688278)</td>
<td>CN¥82.99</td>
<td>CN¥165.09</td>
<td>49.7%</td>
</tr>
<tr>
<td>Takara Bio (TSE:4974)</td>
<td>¥919.00</td>
<td>¥1829.46</td>
<td>49.8%</td>
</tr>
<tr>
<td>Suzhou Zelgen Biopharmaceuticals (SHSE:688266)</td>
<td>CN¥113.00</td>
<td>CN¥223.99</td>
<td>49.6%</td>
</tr>
<tr>
<td>Suzhou Alton Electrical &amp; Mechanical Industry (SZSE:301187)</td>
<td>CN¥29.42</td>
<td>CN¥58.27</td>
<td>49.5%</td>
</tr>
<tr>
<td>Nanjing COSMOS Chemical (SZSE:300856)</td>
<td>CN¥14.28</td>
<td>CN¥28.44</td>
<td>49.8%</td>
</tr>
<tr>
<td>Meitu (SEHK:1357)</td>
<td>HK$9.21</td>
<td>HK$18.02</td>
<td>48.9%</td>
</tr>
<tr>
<td>Matsuya R&amp;DLtd (TSE:7317)</td>
<td>¥731.00</td>
<td>¥1430.21</td>
<td>48.9%</td>
</tr>
<tr>
<td>Kolmar Korea (KOSE:A161890)</td>
<td>₩79000.00</td>
<td>₩155852.26</td>
<td>49.3%</td>
</tr>
<tr>
<td>HL Holdings (KOSE:A060980)</td>
<td>₩42150.00</td>
<td>₩83199.11</td>
<td>49.3%</td>
</tr>
<tr>
<td>Anhui Ronds Science &amp; Technology (SHSE:688768)</td>
<td>CN¥49.18</td>
<td>CN¥97.08</td>
<td>49.3%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>当前价格</strong></td>
<td><strong>公允价值（估算）</strong></td>
<td><strong>折扣（估算）</strong></td>
</tr>
<tr>
<td>厦门特宝生物（SHSE:688278）</td>
<td>CN¥82.99</td>
<td>CN¥165.09</td>
<td>49.7%</td>
</tr>
<tr>
<td>宝丽生物（TSE:4974）</td>
<td>¥919.00</td>
<td>¥1829.46</td>
<td>49.8%</td>
</tr>
<tr>
<td>苏州泽尔根生物制药（SHSE:688266）</td>
<td>CN¥113.00</td>
<td>CN¥223.99</td>
<td>49.6%</td>
</tr>
<tr>
<td>苏州阿尔顿电气与机械工业（SZSE:301187）</td>
<td>CN¥29.42</td>
<td>CN¥58.27</td>
<td>49.5%</td>
</tr>
<tr>
<td>南京宇宙化工（SZSE:300856）</td>
<td>CN¥14.28</td>
<td>CN¥28.44</td>
<td>49.8%</td>
</tr>
<tr>
<td>美图（SEHK:1357）</td>
<td>HK$9.21</td>
<td>HK$18.02</td>
<td>48.9%</td>
</tr>
<tr>
<td>松屋 R&amp;D（TSE:7317）</td>
<td>¥731.00</td>
<td>¥1430.21</td>
<td>48.9%</td>
</tr>
<tr>
<td>Kolmar Korea（KOSE:A161890）</td>
<td>₩79000.00</td>
<td>₩155852.26</td>
<td>49.3%</td>
</tr>
<tr>
<td>HL Holdings（KOSE:A060980）</td>
<td>₩42150.00</td>
<td>₩83199.11</td>
<td>49.3%</td>
</tr>
<tr>
<td>安徽荣德科技（SHSE:688768）</td>
<td>CN¥49.18</td>
<td>CN¥97.08</td>
<td>49.3%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 280 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.</p>
<div class="lb-trans"><p>点击这里查看我们基于现金流的 280 只被低估亚洲股票的完整列表。</p>
</div><p>Let's take a closer look at a couple of our picks from the screened companies.</p>
<div class="lb-trans"><p>让我们更仔细地看看我们筛选出的几只股票。</p>
</div><h2>ASMPT (SEHK:522)</h2>
<div class="lb-trans"><h2>ASMPT（SEHK:522）</h2>
</div><p><strong>Overview:</strong> ASMPT Limited is an investment holding company involved in the design, manufacture, and marketing of machines, tools, and materials for the semiconductor and electronics assembly industries worldwide, with a market cap of approximately HK$29.57 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> ASMPT 有限公司是一家投资控股公司，涉及全球半导体和电子组装行业的机器、工具和材料的设计、制造和营销，市值约为 HK$295.7 亿。</p>
</div><p><strong>Operations:</strong> The company's revenue is derived from Semiconductor Solutions, contributing HK$7.77 billion, and Surface Mount Technology (SMT) Solutions, accounting for HK$5.51 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自半导体解决方案，贡献 HK$77.7 亿，以及表面贴装技术（SMT）解决方案，贡献 HK$55.1 亿。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 44.3%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 44.3%</p>
</div><p>ASMPT appears undervalued based on cash flows, trading at HK$71, significantly below its estimated fair value of HK$127.41. Despite a recent downsizing in Shenzhen to optimize operations, the company maintains robust growth prospects with expected annual earnings growth of 40.6%, outpacing the Hong Kong market's 12.2%. While profit margins have decreased to 1.8% from last year's 3%, ASMPT's strategic realignment aims to enhance cost competitiveness and operational resilience.</p>
<div class="lb-trans"><p>根据现金流，ASMPT 似乎被低估，当前交易价格为 HK$71，远低于其估算的公允价值 HK$127.41。尽管最近在深圳进行了裁员以优化运营，但公司仍保持强劲的增长前景，预计年收益增长为 40.6%，超过香港市场的 12.2%。尽管利润率从去年的 3% 降至 1.8%，ASMPT 的战略调整旨在增强成本竞争力和运营韧性。</p>
</div><ul>
<li>The analysis detailed in our ASMPT growth report hints at robust future financial performance.</li>
<li>Click to explore a detailed breakdown of our findings in ASMPT's balance sheet health report.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们的 ASMPT 增长报告中的分析暗示未来财务表现强劲。</li>
<li>点击探索我们在 ASMPT 资产负债表健康报告中的详细发现。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/d93ad6f1-2b1b-4cae-b992-0cc4eb72e03d/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/d93ad6f1-2b1b-4cae-b992-0cc4eb72e03d/chart/dcf?theme=light"/></p>
<p>SEHK:522 Discounted Cash Flow as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 SEHK:522 折现现金流</p>
</div><h2>Newborn Town (SEHK:9911)</h2>
<div class="lb-trans"><h2>新生镇（SEHK:9911）</h2>
</div><p><strong>Overview:</strong> Newborn Town Inc. is an investment holding company that operates in the social networking business globally, with a market cap of HK$17.13 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 新生镇有限公司是一家投资控股公司，全球运营社交网络业务，市值为 HK$171.3 亿。</p>
</div><p><strong>Operations:</strong> The company generates revenue from two main segments: Innovative Business, contributing CN¥603.10 million, and Social Networking Business, which accounts for CN¥5.40 billion.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自两个主要部门：创新业务，贡献 CN¥6.031 亿，以及社交网络业务，贡献 CN¥54 亿。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 29.5%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 29.5%</p>
</div><p>Newborn Town is trading at HK$12.76, below its estimated fair value of HK$18.09, highlighting its undervaluation based on cash flows. Recent earnings show a strong performance with net income reaching CNY 489.28 million for the first half of 2025, up from CNY 224.68 million the previous year. The company's projected annual earnings growth of 26.5% surpasses the Hong Kong market average, despite recent board changes that may impact strategic direction.</p>
<div class="lb-trans"><p>新生镇的交易价格为 HK$12.76，低于其估算的公允价值 HK$18.09，突显其基于现金流的低估。最近的收益显示出强劲的表现，2025 年上半年净收入达到 CNY 4.8928 亿，较去年 CNY 2.2468 亿有所增长。尽管最近董事会的变动可能影响战略方向，但公司的年收益增长预期为 26.5%，超过香港市场的平均水平。</p>
</div><ul>
<li>According our earnings growth report, there's an indication that Newborn Town might be ready to expand.</li>
<li>Click here and access our complete balance sheet health report to understand the dynamics of Newborn Town.</li>
</ul>
<div class="lb-trans"><ul>
<li>根据我们的收益增长报告，有迹象表明新生镇可能准备扩张。</li>
<li>点击这里访问我们的完整资产负债表健康报告，以了解新生镇的动态。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/fcd5c300-fa92-45a8-85b8-008e7212a467/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/fcd5c300-fa92-45a8-85b8-008e7212a467/chart/dcf?theme=light"/></p>
<p>SEHK:9911 Discounted Cash Flow as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 SEHK:9911 折现现金流</p>
</div><h2>Rorze (TSE:6323)</h2>
<div class="lb-trans"><h2>Rorze（TSE:6323）</h2>
</div><p><strong>Overview:</strong> Rorze Corporation designs, develops, manufactures, and sells automation systems for semiconductor and flat panel display production globally, with a market cap of ¥312.87 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Rorze 公司设计、开发、制造和销售全球半导体和液晶显示器生产的自动化系统，市值为¥3128.7 亿。</p>
</div><p><strong>Operations:</strong> The company generates revenue from the design, development, manufacture, and sale of automation systems for semiconductor and flat panel display production globally.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入来自全球半导体和液晶显示器生产的自动化系统的设计、开发、制造和销售。</p>
</div><p><strong>Estimated Discount To Fair Value:</strong> 34.2%</p>
<div class="lb-trans"><p><strong>公允价值折扣估算：</strong> 34.2%</p>
</div><p>Rorze, trading at ¥1804, is significantly undervalued compared to its estimated fair value of ¥2740.71. Despite a decline in profit margins from 23.4% to 15.7%, the company remains a good value, trading 34.2% below fair value estimates. Earnings are forecasted to grow annually by 15.81%, outpacing the Japanese market average of 8.3%. Recent completion of a share buyback program worth ¥4,999.94 million may enhance shareholder value amidst high share price volatility.</p>
<div class="lb-trans"><p>Rorze 的交易价格为¥1804，显著低于其估算的公允价值¥2740.71。尽管利润率从 23.4% 降至 15.7%，但公司仍然具有良好的价值，交易价格比公允价值估算低 34.2%。预计年收益将增长 15.81%，超过日本市场的平均水平 8.3%。最近完成的价值¥49.9994 亿的股票回购计划可能在高股价波动中提升股东价值。</p>
</div><ul>
<li>Our comprehensive growth report raises the possibility that Rorze is poised for substantial financial growth.</li>
<li>Get an in-depth perspective on Rorze's balance sheet by reading our health report here.</li>
</ul>
<div class="lb-trans"><ul>
<li>我们的综合增长报告提出 Rorze 可能面临显著的财务增长机会。</li>
<li>点击这里阅读我们的健康报告，深入了解 Rorze 的资产负债表。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/4d659f8c-73ac-4638-abf7-18dec4e4fb14/chart/dcf/query-dGhlbWU9bGlnaHQ" alt="" original-src="https://images.simplywall.st/company/4d659f8c-73ac-4638-abf7-18dec4e4fb14/chart/dcf?theme=light"/></p>
<p>TSE:6323 Discounted Cash Flow as at Sep 2025</p>
<div class="lb-trans"><p>截至 2025 年 9 月的 TSE:6323 折现现金流</p>
</div><h2>Make It Happen</h2>
<div class="lb-trans"><h2>让它发生</h2>
</div><ul>
<li>Click here to access our complete index of 280 Undervalued Asian Stocks Based On Cash Flows.</li>
<li>Already own these companies? Bring clarity to your investment decisions by linking up your portfolio with Simply Wall St, where you can monitor all the vital signs of your stocks effortlessly.</li>
<li>Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们完整的 280 只基于现金流的被低估亚洲股票索引。</li>
<li>已经拥有这些公司？通过将您的投资组合与 Simply Wall St 连接，清晰化您的投资决策，您可以轻松监控所有股票的关键指标。</li>
<li>使用 Simply Wall St 应用程序提升您的投资能力，享受免费访问涵盖每个大洲的市场情报。</li>
</ul>
</div><h2>Ready To Venture Into Other Investment Styles?</h2>
<div class="lb-trans"><h2>准备探索其他投资风格吗？</h2>
</div><ul>
<li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li>
<li>Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.</li>
<li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li>
</ul>
<div class="lb-trans"><ul>
<li>探索尚未获得显著分析师关注的高表现小型公司。</li>
<li>通过稳健的分红支付者来多样化您的投资组合，以提供可靠的收入来源，以应对潜在的市场动荡。</li>
<li>充实您的投资组合，选择那些显示出强劲增长潜力的公司，这些公司得到了分析师和管理层的乐观展望支持。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation.</strong> We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章来自 Simply Wall St，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章并不构成财务建议。它不构成购买或出售任何股票的推荐，也未考虑您的目标或财务状况。</strong> 我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div>

亚洲价值股在 2025 年 9 月提供的预期机会